Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales in clinical groups and a community sample.
- M. Antony, P. Bieling, B. Cox, M. Enns, R. Swinson
- Psychology
- 1 June 1998
The factor structure, reliability, and validity of the Depression Anxiety Stress Scales (DASS; S. H. Lovibond & P. F. Lovibond, 1995) and the 21-item short form of these measures (DASS-21) were… Expand
The State-Trait Anxiety Inventory, Trait version: structure and content re-examined.
- P. Bieling, M. Antony, R. Swinson
- Psychology, Medicine
- Behaviour research and therapy
- 1 August 1998
Although the State-Trait Anxiety Inventory (STAI) is a popular measure of anxiety, some previous research suggests that the trait scale may assess depression, as well as anxiety. The factor structure… Expand
Dimensions of perfectionism across the anxiety disorders.
- M. Antony, C. Purdon, V. Huta, R. Swinson
- Psychology, Medicine
- Behaviour research and therapy
- 1 December 1998
To explore the role of perfectionism across anxiety disorders, 175 patients with either panic disorder (PD), obsessive compulsive disorder (OCD), social phobia, or specific phobia, as well as 49… Expand
Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study.
- M. Van Ameringen, R. Lane, +9 authors R. Swinson
- Psychology, Medicine
- The American journal of psychiatry
- 1 February 2001
OBJECTIVE
The authors evaluated the efficacy, safety, and tolerability of sertraline, a selective serotonin reuptake inhibitor, in the treatment of generalized social phobia.
METHOD
Adult… Expand
Psychometric properties of the social phobia inventory: further evaluation.
- M. Antony, Michael J. Coons, R. McCabe, Andrea Ashbaugh, R. Swinson
- Psychology, Medicine
- Behaviour research and therapy
- 1 August 2006
This study investigated the psychometric properties of the Social Phobia Inventory [SPIN; Connor, K. M., Davidson, J. R. T., Churchill, L. E., Sherwood, A., Foa, E., Wesler, R.H., 2000. Psychometric… Expand
Anger experience and expression across the anxiety disorders
- D. Moscovitch, R. McCabe, M. Antony, L. Rocca, R. Swinson
- Psychology, Medicine
- Depression and anxiety
- 1 February 2008
The purpose of this study was to explore possible differences in the experience and expression of anger across four anxiety disorder groups and non‐clinical controls. Anger was assessed by two… Expand
Symptom structure in obsessive-compulsive disorder: a confirmatory factor-analytic study.
- L. Summerfeldt, M. Richter, M. Antony, R. Swinson
- Psychology, Medicine
- Behaviour research and therapy
- 1 April 1999
Although obsessive-compulsive disorder (OCD) has long been a unitary diagnosis, there is much recent interest in its potential heterogeneity, as manifested by symptom subgroups. This study evaluated… Expand
Smoking behaviors across anxiety disorders.
- R. McCabe, Susan M Chudzik, M. Antony, L. Young, R. Swinson, Michael J Zolvensky
- Psychology, Medicine
- Journal of anxiety disorders
- 2004
The purpose of this study was to test the theory put forth by Zvolensky et al. [Clin. Psychol. Sci. Pract. 10 (2003) 29] that smoking is specifically associated with panic disorder (PD) and not more… Expand
Examining an obsessive-compulsive core dimensions model: Structural validity of harm avoidance and incompleteness.
- L. Summerfeldt, Patricia H. Kloosterman, M. Antony, R. Swinson
- Psychology
- 1 April 2014
Abstract Building upon work by Rasmussen and Eisen, our group has proposed a model comprising two core motivational dimensions underlying obsessive-compulsive symptoms: harm avoidance and… Expand
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
- J. Ballenger, G. D. Burrows, +5 authors R. Swinson
- Psychology, Medicine
- Archives of general psychiatry
- 1 May 1988
Following promising preliminary evidence, the benzodiazepine-derivative alprazolam was studied in a large, placebo-controlled, eight-week, flexible-dose trial in patients with agoraphobia with panic… Expand